Mon, July 11, 2011
Sun, July 10, 2011
Sat, July 9, 2011
Fri, July 8, 2011
Thu, July 7, 2011
Wed, July 6, 2011
[ Wed, Jul 06th 2011 ] - Market Wire
Larry Renfro Named CEO of Optum
Tue, July 5, 2011
Mon, July 4, 2011
Sat, July 2, 2011
Fri, July 1, 2011
Thu, June 30, 2011
[ Thu, Jun 30th 2011 ] - Market Wire
KCI???NPWT????????????
Wed, June 29, 2011
Tue, June 28, 2011
Mon, June 27, 2011
Sat, June 25, 2011
Fri, June 24, 2011
Thu, June 23, 2011
Wed, June 22, 2011
Tue, June 21, 2011
Mon, June 20, 2011
Sun, June 19, 2011
Fri, June 17, 2011
Thu, June 16, 2011
Wed, June 15, 2011

The Law Firm of Levi & Korsinsky, LLP Announces Investigation of Tiens Biotech Group (USA), Inc.


//health-fitness.news-articles.net/content/2011/ .. nvestigation-of-tiens-biotech-group-usa-inc.html
Published in Health and Fitness on Monday, June 27th 2011 at 10:50 GMT by Market Wire   Print publication without navigation


NEW YORK--([ BUSINESS WIRE ])--Levi & Korsinsky is investigating the Board of Directors of Tiens Biotech Group (USA), Inc. (aTiens Biotecha or athe Companya) (AMEX: TBV) for possible breaches of fiduciary duty and other violations of state law in connection with the receipt of a merger proposal from the Companya™s Chairman and CEO, Jinyuan Li. Under the terms of the transaction, Tiens Biotech shareholders would receive $1.72 per share of Tiens Biotech stock they own. Mr. Li currently owns more than 95% of the Companya™s outstanding shares.

Click here to learn how to join the action: [ http://www.zlk.com/tiens-biotech ], or call: 877-363-5972.

The investigation concerns whether the Tiens Biotech Board of Directors is adequately shopping the Company and taking the necessary steps to obtain the best possible price for Tiens Biotech shareholders. In particular, Tiens Biotech reported a book value of $2.67 per share for the most recent quarter.

If you own common stock in Tiens Biotech and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at [ jlevi@zlk.com ] or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit [ http://www.zlk.com ].

Levi & Korsinsky has expertise in prosecuting investor securities litigation and extensive experience in actions involving financial fraud and represents investors throughout the nation, concentrating its practice in securities and shareholder litigation. The attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major litigations involving mergers and acquisitions. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.


Publication Contributing Sources